Literature DB >> 7640457

Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.

S Yasuda1, S Raja, K F Hubner.   

Abstract

We describe herein a case of esophageal cancer in which both primary and metastatic lymph node foci were successfully imaged with whole-body positron emission tomography (PET) scanning. A 75-year-old woman with biopsy-proven squamous cell carcinoma of the esophagus underwent whole-body PET scanning for staging evaluation. The patient was injected with 373.7 MBq [18F]-2-fluoro-2-D-deoxyglucose (FDG), and 60 min later, scanning was performed from the neck to the pelvis. The whole-body images showed intense FDG uptake in the primary lesion and multiple focal areas of increased FDG uptake in the mediastinum and abdomen, which corresponded to the lymph node foci confirmed by computed tomography (CT) scan. To our knowledge, this is the first report of whole-body PET scanning being applied in the imaging of esophageal cancer.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7640457     DOI： 10.1007/bf00311538

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  20 in total

Review 1.  The role of positron emission tomography in oncology and other whole-body applications.

Authors:  R A Hawkins; C Hoh; J Glaspy; Y Choi; M Dahlbom; S Rege; C Messa; E Nietszche; E Hoffman; L Seeger
Journal:  Semin Nucl Med       Date:  1992-10       Impact factor: 4.446

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  PET scanning in oncology.

Authors:  C B Wilson
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

4.  Oxygen consumption and anaerobic glycolysis of human malignant and normal tissue.

Authors:  R A MACBETH; J G BEKESI
Journal:  Cancer Res       Date:  1962-02       Impact factor: 12.701

5.  Recurrence of colorectal tumors: PET evaluation.

Authors:  L G Strauss; J H Clorius; P Schlag; B Lehner; B Kimmig; R Engenhart; M Marin-Grez; F Helus; F Oberdorfer; P Schmidlin
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

Review 6.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

7.  The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.

Authors:  N Y Tse; C K Hoh; R A Hawkins; M J Zinner; M Dahlbom; Y Choi; J Maddahi; F C Brunicardi; M E Phelps; J A Glaspy
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

8.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Authors:  R L Wahl; R L Cody; G D Hutchins; E E Mudgett
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

9.  Carcinoma of the esophagus: CT vs MR imaging in determining resectability.

Authors:  S Takashima; N Takeuchi; H Shiozaki; K Kobayashi; S Morimoto; J Ikezoe; N Tomiyama; K Harada; K Shogen; T Kozuka
Journal:  AJR Am J Roentgenol       Date:  1991-02       Impact factor: 3.959

10.  Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.

Authors:  S Okazumi; K Isono; K Enomoto; T Kikuchi; M Ozaki; H Yamamoto; H Hayashi; T Asano; M Ryu
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057
View more
  5 in total

1.  A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: report of two cases.

Authors:  Atsushi Takeno; Shuji Takiguchi; Makoto Yamasaki; Hiroshi Miyata; Ryohei Kawabata; Yoichiro Nushijima; Tomoki Makino; Yoshiyuki Fujiwara; Kiyokazu Nakajima; Toshiro Nishida; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

2.  Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.

Authors:  S Yasuda; H Makuuchi; S Sadahiro; M Mukai; H Ishida; N Tokunaga; T Kimura; T Tajima; A Shohtsu
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

4.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

5.  Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.

Authors:  A C Kole; J T Plukker; O E Nieweg; W Vaalburg
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.